FDA inspection
SOLA Pharmaceuticals LLC: FDA inspection ending Dec 18, 2024
FDA inspection 1256965 · Voluntary Action Indicated (VAI) · Baton Rouge, LA
Key facts
| Inspection ID | 1256965 |
|---|---|
| Firm | SOLA Pharmaceuticals LLC |
| FEI number | 3014030941 |
| Address | 655 Highlandia Dr Ste B |
| City | Baton Rouge |
| State | LA |
| ZIP | 70810 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Dec 18, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data